(Q34540811)

English

Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxin

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxin (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

phase II clinical trial

0 references

0 references

Peter W de Leeuw

7

object named as

Peter W de Leeuw

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

object named as

Yuri Nikitin

13

0 references

object named as

Paolo Manunta

11

0 references

Jan A. Staessen

object named as

Jan A Staessen

1

0 references

Katarzyna Stolarz-Skrzypek

3

object named as

Katarzyna Stolarz-Skrzypek

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Kalina Kawecka-Jaszcz

21

object named as

Kalina Kawecka-Jaszcz

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Andrzej Tykarski

18

object named as

Andrzej Tykarski

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Mirosław Dłużniewski

8

object named as

Mirosław Dłużniewski

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Giuseppe Bianchi

22

object named as

Giuseppe Bianchi

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Andrzej Januszewicz

10

object named as

Andrzej Januszewicz

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Lorena Citterio

object named as

Lorena Citterio

16

1 reference

ORCID Public Data File 2021

15

object named as

Chiara Lanzani

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

2

object named as

Lutgarde Thijs

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Antonella Bacchieri

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

John Barton

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Ezio Degli Espositi

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Nicola Glorioso

9

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Viktor Milyagin

12

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Miroslav Souček

14

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Mario Timio

17

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Patrizia Ferrari

19

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Giovanni Valentini

20

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

publication date

14 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

14 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

https://scigraph.springernature.com/pub.10.1186/1745-6215-12-13

0 references

Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031200

7 July 2018

The endogenous ouabain: molecular basis of its role in hypertension and cardiovascular complications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031200

7 July 2018

beta-Adducin polymorphisms, blood pressure, and sodium excretion in three European populations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031200

7 July 2018

Gene-environment interactions and the etiology of common complex disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031200

7 July 2018

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031200

7 July 2018

OASIS-HT: design of a pharmacogenomic dose-finding study

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-12-13

21 January 2018

Quality control of the blood pressure phenotype in the European Project on Genes in Hypertension.

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-12-13

21 January 2018

Prediction of the actual awake and asleep blood pressures by various methods of 24 h pressure analysis

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-12-13

21 January 2018

Epistatic interaction between alpha- and gamma-adducin influences peripheral and central pulse pressures in white Europeans

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-12-13

21 January 2018

Left ventricular mass in relation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretion.

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-12-13

21 January 2018

Identification and chromosomal localization of ecogenetic components of electrolyte excretion.

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-12-13

21 January 2018

Salt, endogenous ouabain and blood pressure interactions in the general population

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-12-13

21 January 2018

Plasma ouabain-like factor during acute and chronic changes in sodium balance in essential hypertension.

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-12-13

21 January 2018

Left ventricular geometry and endogenous ouabain in a Flemish population

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-12-13

21 January 2018

17 beta-(3-furyl)-5 beta-androstane-3 beta, 14 beta, 17 alpha-triol (PST 2238). A very potent antihypertensive agent with a novel mechanism of action

1 reference

https://pubmed.ncbi.nlm.nih.gov/21235787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/21235787

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1745-6215-12-13

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34540811&oldid=1966723833"